BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

221 related articles for article (PubMed ID: 33400967)

  • 1. CCRD based development of bromocriptine and glutathione nanoemulsion tailored ultrasonically for the combined anti-parkinson effect.
    Ashhar MU; Kumar S; Ali J; Baboota S
    Chem Phys Lipids; 2021 Mar; 235():105035. PubMed ID: 33400967
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Amelioration of oxidative stress utilizing nanoemulsion loaded with bromocriptine and glutathione for the management of Parkinson's disease.
    Usama Ashhar M; Vyas P; Vohora D; Kumar Sahoo P; Nigam K; Dang S; Ali J; Baboota S
    Int J Pharm; 2022 Apr; 618():121683. PubMed ID: 35314276
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Design Expert(®) supported optimization and predictive analysis of selegiline nanoemulsion via the olfactory region with enhanced behavioural performance in Parkinson's disease.
    Kumar S; Ali J; Baboota S
    Nanotechnology; 2016 Oct; 27(43):435101. PubMed ID: 27655136
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intranasal delivery of paroxetine nanoemulsion via the olfactory region for the management of depression: formulation, behavioural and biochemical estimation.
    Pandey YR; Kumar S; Gupta BK; Ali J; Baboota S
    Nanotechnology; 2016 Jan; 27(2):025102. PubMed ID: 26629830
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Attenuation of Oxidative Damage by Coenzyme Q
    Gupta BK; Kumar S; Kaur H; Ali J; Baboota S
    Rejuvenation Res; 2018 Jun; 21(3):232-248. PubMed ID: 28844183
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Vitamin E loaded resveratrol nanoemulsion for brain targeting for the treatment of Parkinson's disease by reducing oxidative stress.
    Pangeni R; Sharma S; Mustafa G; Ali J; Baboota S
    Nanotechnology; 2014 Dec; 25(48):485102. PubMed ID: 25392203
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Vitamin E Loaded Naringenin Nanoemulsion via Intranasal Delivery for the Management of Oxidative Stress in a 6-OHDA Parkinson's Disease Model.
    Gaba B; Khan T; Haider MF; Alam T; Baboota S; Parvez S; Ali J
    Biomed Res Int; 2019; 2019():2382563. PubMed ID: 31111044
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ultrasonically tailored, chemically engineered and "QbD" enabled fabrication of agomelatine nanoemulsion; optimization, characterization, ex-vivo permeation and stability study.
    Ahmed S; Gull A; Alam M; Aqil M; Sultana Y
    Ultrason Sonochem; 2018 Mar; 41():213-226. PubMed ID: 29137746
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impact of ultrasonication techniques on the preparation of novel Amiloride-nanoemulsion used for intranasal delivery in the treatment of epilepsy.
    Ahmad N; Ahmad R; Alam MA; Ahmad FJ; Amir M
    Artif Cells Nanomed Biotechnol; 2018; 46(sup3):S192-S207. PubMed ID: 30032652
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Selegiline Nanoformulation in Attenuation of Oxidative Stress and Upregulation of Dopamine in the Brain for the Treatment of Parkinson's Disease.
    Kumar S; Dang S; Nigam K; Ali J; Baboota S
    Rejuvenation Res; 2018 Oct; 21(5):464-476. PubMed ID: 29717617
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Chitosan coated synergistically engineered nanoemulsion of Ropinirole and nigella oil in the management of Parkinson's disease: Formulation perspective and In vitro and In vivo assessment.
    Nehal N; Nabi B; Rehman S; Pathak A; Iqubal A; Khan SA; Yar MS; Parvez S; Baboota S; Ali J
    Int J Biol Macromol; 2021 Jan; 167():605-619. PubMed ID: 33278450
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Role of Rutin Nanoemulsion in Ameliorating Oxidative Stress: Pharmacokinetic and Pharmacodynamics Studies.
    Sharma S; Rabbani SA; Narang JK; Hyder Pottoo F; Ali J; Kumar S; Baboota S
    Chem Phys Lipids; 2020 May; 228():104890. PubMed ID: 32032570
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bromocriptine Nanoemulsion-Loaded Transdermal Gel: Optimization Using Factorial Design, In Vitro and In Vivo Evaluation.
    Sita V G ; Vavia P
    AAPS PharmSciTech; 2020 Jan; 21(3):80. PubMed ID: 31975311
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Intranasal delivery of tetrabenazine nanoemulsion via olfactory region for better treatment of hyperkinetic movement associated with Huntington's disease: Pharmacokinetic and brain delivery study.
    Arora A; Kumar S; Ali J; Baboota S
    Chem Phys Lipids; 2020 Aug; 230():104917. PubMed ID: 32439327
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Development and optimization of nanoemulsion based gel for enhanced transdermal delivery of nitrendipine using box-behnken statistical design.
    Sharma A; Singh AP; Harikumar SL
    Drug Dev Ind Pharm; 2020 Feb; 46(2):329-342. PubMed ID: 31976777
    [No Abstract]   [Full Text] [Related]  

  • 16. Development and characterization of nanoemulsion as carrier for the enhancement of bioavailability of artemether.
    Laxmi M; Bhardwaj A; Mehta S; Mehta A
    Artif Cells Nanomed Biotechnol; 2015; 43(5):334-44. PubMed ID: 24641773
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of high-pressure homogenization on formulation of TPGS loaded nanoemulsion of rutin - pharmacodynamic and antioxidant studies.
    Sharma S; Sahni JK; Ali J; Baboota S
    Drug Deliv; 2015; 22(4):541-51. PubMed ID: 24625264
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Design and development of letrozole nanoemulsion: A comparative evaluation of brain targeted nanoemulsion with free letrozole against status epilepticus and neurodegeneration in mice.
    Iqbal R; Ahmed S; Jain GK; Vohora D
    Int J Pharm; 2019 Jun; 565():20-32. PubMed ID: 31051232
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nanoemulsions for Intranasal Delivery of Riluzole to Improve Brain Bioavailability: Formulation Development and Pharmacokinetic Studies.
    Parikh RH; Patel RJ
    Curr Drug Deliv; 2016; 13(7):1130-1143. PubMed ID: 26638977
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Biopharmaceutical Potential of Selegiline Loaded Chitosan Nanoparticles in the Management of Parkinson's Disease.
    Rukmangathen R; Yallamalli IM; Yalavarthi PR
    Curr Drug Discov Technol; 2019; 16(4):417-425. PubMed ID: 29669501
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.